Program
monday
14.00-15.30
Educational workshop
14.00 – Imaging patterns in ILDs, Helmut Prosch (Austria), Athir Eddan (Romania)
15.00 – How imaging patterns are integrated in MDD, Athol Wells (UK)
Chairs: Helmut Prosch (Austria), Athol Wells (UK)
15.30-16.30
Educational workshop
15.30 – Cryobiopsy – guidelines, tips and tricks, Venerino Poletti (Italy)
16.10 – Which patients should undergo cryobiopsy Ionela Belaconi (Romania), Silviu Dumitru (Romania)
Chairs: Venerino Poletti (Italy), Silviu Dumitru (Romania)
16.30-17.00
Coffee Break
17.00-18.00
Workshop/roundtable
Future of clinical trials, Daniel Culver (USA), Luca Richeldi (Italy)
18.00-18.30
Networking
18.30
Opening ceremony/cocktail
tuesday
8.30-10.10
Pulmonary fibrosis – the basics
8.30 – Novel insights into pathogenesis, Katerina Antoniou (Greece)
9.00 – Genetics in ILDs – time to act, Jan Grutters (Nieuwegein, The Netherlands)
9.25 – Biomarkers of progression, Francesco Bonella (Germany)
9.50 – Cardiac consequences of pulmonary fibrosis, Roxana Maria Nemeș (Romania)
Chairs: Ionela Belaconi (Romania), Ganesh Raghu (USA)
10.10-10.40
Coffee Break
10.40-13.00
IPF and PF-ILD
10.40 – New treatments in PF, Luca Richieldi (Italy)
11.05 – Acute exacerbations in pulmonary fibrosis, Azuma Arata (Japan)
11.30 – IPF diagnosis: guideline recommendations, Ganesh Raghu (USA)
12.00 – Primary and secondary UIP: a unified diagnostic entity?, Athol Wells (UK)
12.30 – Advances in non-IPF pulmonary fibrosis, Marlies Wijsenbeek (The Netherlands)
Chairs: Daniel Trăilă (Romania), Jan Grutters (Nieuwegein, The Netherlands)
13.00-14.00
Lunch Break
14.00-15.00
Poster discussion
Peritoneal Sarcoidosis or Peritoneal Tuberculosis? A Challenging Case, Shambhu Aryal (USA)
A Case of Refractory Pulmonary Mycetoma in a Patient with Sarcoidosis Treated with CT guided Percutaneous Cryoablation, Shambhu Aryal (USA)
Outcomes of ECMO in acute exacerbation of interstitial pneumonia are comparable to those of non-interstitial pneumonia, Shinichiro Ohshimo (Japan)
IPF, Ioana Dinu (Romania)
Non-smoker presenting with hemoptysis – unexpected diagnosis, Marius Alexandru Cotet (Romania)
The Differential characteristics of IPF and non-IPF ILD patients under antidiabetic treatment; disease progression and bronchoalveolar lavage (BAL) evaluation, Eirini Vasarmidi (Greece)
The limitations of the histopathological examination in the differential diagnosis of pulmonary tuberculosis vs sarcoidosis – clinical case presentation, Viorica Zamfir (Romania)
Silicosis and Sjogren syndrome – the reinforcement of an association, Margarida Afonso (Portugal)
Anti – MPO vasculitis meets RB – ILD, Diogo Canhoto (Portugal)
Chairs: Jan Grutters (Nieuwegein, The Netherlands), Wim Wuyts (Belgium)
15.00-16.00
Roundtable
Patient organizations session, Liam Galvin (Ireland), Steve Jones (Ireland)
Chairs: Irina Strâmbu (Romania), Robert Arsene (Romania)
16.00-16.30
Coffee Break
16.30-17.30
ILDs: Early diagnosis
16.30 – Interstitial lung abnormalities, Sara Tomassetti (Italy)
17.00 – Early diagnosis for ILDs, Wim Wuyts (Belgium)
Chairs: Radu Crișan Dabija (Romania), Claudia Ravaglia (Italy)
17.30-18.30
Pharma Boehringer Ingelheim
Progressive Pulmonary Fibrosis: Myths and Facts
17.30 – Welcome and introductions, Marlies Wijsenbeek (The Netherlands)
17.35 – It is important for patients with ILD to receive an accurate differential diagnosis? Myth or fact?, Maria Molina Molina (Spain)
17.50 – There are multiple drugs approved to treat PF ILD – Myth or fact?, Marlies Wijsenbeek (The Netherlands)
18.05 – The INBUILD trial was a collection of trials in individual diseases – Myth or fact?, Luca Richieldi (Italy)
18.20 – Q&A session, Faculty
Chairs: Marlies Wijsenbeek (The Netherlands)
Later
Speakers dinner
wednesday
08.30-10.10
ILDs and post Covid
8.30 – ERS Task Force on Post-Covid ILDs, Maria Molina Molina (Spain)
9.00 – Clinical, morphological and radiological features of Post-covid ILDs, Claudia Ravaglia (Italy)
9.30 – Post-Covid ILD -Romanian experience, Diana Manolescu (Romania)
9.50 – Telemedicine and Covid-19, Ovidiu Fira Mlădinescu (Romania)
Chairs: Wim Wuyts (Belgium), Antigona Trofor (Romania)
10.30-11.00
Coffee Break
11.00-12.30
Sarcoidosis
11.00 – New guidelines in sarcoidosis, Irina Strâmbu (Romania)
11.30 – CT patterns in sarcoidosis, Helmut Prosch (Austria)
12.00 – Impact and limitations of sarcoidosis, Marjolein Drent (The Netherlands)
Chairs: Jacob Sellares Torres (Spain), Diana Ioniță (Romania)
12.30-13.30
Lunch Break
13.30-14.30
Poster discussion
Sarcoidosis
Histochemical evaluation of 3 key inflammatory pathways in sarcoid granulomas, Raisa Kraaijvanger (The Netherlands)
Quantitative Sensory Testing is Valuable for Diagnosing Sarcoidosis Associated Small Fiber Neuropathy, Lisette Raasing (The Netherlands)
Pulmonary hypertension associated genetic variants in sarcoidosis associated pulmonary hypertension, Karlijn Groen (The Netherlands)
Artificial Intelligence Enabled Electrocardiography Identifies Reduced Left Ventricular Ejection Fraction in Patients Diagnosed with Cardic Sarcoidosis, Melanie Bratcher (USA)
The relation between methotrexate polyglutamate concentrations and treatment effect of methotrexate in sarcoidosis. A pilot study, Montse Janssen Bonas (The Netherlands)
Sarcoidosis – imaging chameleon, Ovidiu Cîmpeanu (Romania)
Heerfordt syndrome – an unexpected diagnosis in a former MDR TB patient, Diana Calaras (Romania)
Sarcoidosis and tuberculosis: when complicated things get more complicated, Diana Calaras (Romania)
Development of Extracardiac Sarcoidosis After Heart Transplant Identifying Cardiac Sarcoidosis as Culprit, Anneka Hutton (UK)
Case report of sarcoidosis, Jelica Videnovic – Ivanov (Serbia)
Role of Serum Soluble Interleukin – 2 Receptor Level in the Diagnosisof Sarcoidosis: A Systematic Review and Meta – Analysis, Samiksha Gupta
Chairs: Radu Crișan Dabija (Romania), Jacob Sellares Torres (Spain)
14.30-16.00
Hypersensitivity pneumonitis
14.30 – Practical approach to diagnosis and treatment of HP in the light of new guidelines, Martina Koziar -Vasakova (Czech Republic)
15.00 – BAL in HP (and other ILDs), Ulrich Costabel (Germany)
15.30 – Occupational ILDs, Marina Oțelea (Romania)
Chairs: Milena Man (Romania), Tudor Constantinescu (Romania)
16.00-16.30
Coffee Break
16.30-17.00
Pharma – Kinevant
Evaluation of an Anti-GM-CSF Monoclonal Antibody (Namilumab) in a Phase 2 Pulmonary Sarcoidosis Trial, Robert Baughman (USA), Kiyomi Komori (USA)
Chairs: Irina Strâmbu (Romania)
17.00-18.30
Sarcoidosis
17.00 – Extrapulmonary sarcoidosis, Dan Culver (USA)
17.30 – Diagnosis: when biopsy is not needed, Robert Baughman (USA)
18.00 – New treatments in sarcoidosis, Robert Baughman (USA)
Chairs: Irina Strâmbu (Romania), Katerina Antoniou (Greece)
20.00
Gala Dinner
Thursday
08.30-10.00
ILDs and more…
8.30 – Pulmonary Alveolar Proteinosis: on the verge of a breakthrough, Francesco Bonella (Germany)
8.55 – ILDs and pulmonary hypertension, Tudor Constantinescu (Romania) .
9.20 – Non-pharmacological treatments ILDs, Cristian Oancea (Romania), Alexandru Crișan (Romania)
9.45 – Lung transplant for ILDs, Dragos Bumbacea (Romania)
Chairs: Daniel Trăilă (Romania), Antigona Trofor (Romania)
10.00-10.30
Coffee Break
10.30-12.00
Systemic diseases and ILDs
10.30 – Pulmonologist/rheumathologist perspective on CTD-ILDs, Anna – Maria Hoffmann – Vold (Norway), Katerina Antoniou (Greece)
11.30 – Antisynthetase syndrome, Milena Man (Romania)
Chairs: Ionela Belaconi (Romania), Athol Wells (UK)
12.00-12.30
Interactive clinical cases – “Lungs on fire”
12.00 – Radu Crisan (Romania)
12.20 – Claudiu Iordache (Romania)
12.40 – Ionela Belaconi (Romania)
13.00 – Tudor Constantinescu (Romania)
13.20 – Daniel Traila (Romania)
Discussants: Irina Strâmbu (Romania), Ulrich Costabel (Germany), Daniel Trăilă (Romania), Diana Manolescu (Romania)
Chairs: Dragoș Bumbăcea (Romania), Tudor Constantinescu (Romania)
